According to a McMaster University news release marking World AMR Awareness Week, researchers at the Ontario institution have achieved a string of breakthroughs in the fight against antimicrobial resistance (AMR) over the past year. The university's strength in infectious disease research was recently recognized by the journal Nature, which ranked McMaster among the top 100 organizations worldwide for the field.
Much of modern medicine depends on the ability to control infections reliably, the release notes. Antibiotics and other antimicrobials make it possible to treat once-deadly diseases, perform complex surgeries, transplant organs, deliver babies by C-section, and administer cancer treatments safely. But these medicines are losing effectiveness as bacteria, fungi, and other microbes evolve new ways to withstand the drugs that once killed them.
Here are the 10 research achievements McMaster highlighted from the past year:
1. A new antibiotic and a new way to kill bacteria
A team led by Professor Gerry Wright discovered a new antibiotic called manikomycin that kills some of the world's most dangerous and drug-resistant bacteria by targeting a previously unknown vulnerability, according to the release. Published in Nature, the compound showed early effectiveness against priority pathogens including Salmonella, E. coli, and Klebsiella. It marked the fourth new antimicrobial candidate identified by Wright's lab in just over a year.
2. A 'megacluster' of genes produces a coordinated antibiotic arsenal
Researchers led by Professor Eric Brown discovered what they describe as a "megacluster" of genes in Streptomyces bacteria that produces four antibiotics working together to stop rival bacteria, the release states. Also published in Nature, the study described an unusual stretch of DNA encoding four distinct families of natural product antibiotics, including one compound entirely new to science and another never before recognized as an antibiotic. The four molecules target a single vulnerability: biotin (vitamin B7), an essential nutrient most bacteria need to survive. The antibiotics disrupt biotin production, uptake, and use, offering a new model for how antibiotics can work together.
3. AI-designed antibiotic shows promise in early tests
Researchers led by Jon Stokes developed a new generative AI model called SyntheMol-RL that can explore a vast chemical space of up to 46 billion possible compounds, according to McMaster. The team tasked it with generating new antibiotics against Staphylococcus aureus. From 79 model-proposed antibacterials, they homed in on a novel, water-soluble compound called synthecin. Formulated as a topical cream and tested on drug-resistant wound infections in mouse models, synthecin was highly effective at controlling the infection, the release reports.
4. National antibiotic prescribing recommendations rolled out
Researchers at McMaster developed and released new recommendations to improve antibiotic prescribing across Canada, the release says. Commissioned by the Public Health Agency of Canada in 2024, the Canadian Antibiotic Treatment Guidance is designed to promote more prudent antibiotic use under the stewardship pillar of Canada's Pan-Canadian Action Plan on AMR. It is now available to prescribers nationwide via the Firstline health technology platform.
5. 'Helper molecule' boosts effectiveness against drug-resistant fungi
McMaster researchers identified a molecule called butyrolactol A that synergizes with existing drugs to target the deadly and notoriously drug-resistant fungus Cryptococcus neoformans, according to the release. Butyrolactol A is not an antifungal itself but an adjuvant — a helper molecule that bolsters the effectiveness of existing medicines. With a stagnant antifungal drug pipeline and rising resistance, scientists are betting on adjuvants as a solution.
6. Antimicrobial chemicals discovered on human skin
A study out of McMaster revealed that many members of the skin microbiome produce antimicrobial chemicals capable of warding off invading microbes, the release reports. In early tests, these newly identified chemicals inhibited several different kinds of disease-causing fungi, including otherwise drug-resistant ones.
7. $2M funding to advance precision antibiotic for IBD toward human trials
In fall 2025, Stokes discovered enterololin, a potent new antibiotic with potential to treat inflammatory bowel diseases like Crohn's, the release states. With more than $2 million in fresh funding from the Weston Family Foundation, the drug candidate could advance to clinical trials in just three years. Enterololin works by surgically targeting dangerous gut bacteria while leaving beneficial microbes unscathed — a stark contrast to broad-spectrum antibiotics that take out good and neutral microbes along with the ones causing infection.
8. Focus on multicellular microbes for new antibiotics
McMaster researchers identified a biological pattern that could guide the search for new medicines, according to the release. Published in Nature Microbiology, the study showed that microbes that have evolved multicellular lifestyles are especially rich sources of natural compounds that underpin many antibiotics and other drugs, compared to their single-celled counterparts. The findings could help researchers worldwide narrow their search for medically relevant chemistry.
9. Phage protein disarms dangerous bacteria
Researchers discovered that a protein called Aqs1, produced by phages (viruses that infect bacteria), can disarm multiple disease-causing bacteria, the release reports. The protein shuts down the molecular machinery that allows bacteria to build fibres that help them move, stick to surfaces and host tissues, and carry out other functions that contribute to disease.
10. New understanding of bacterial chemistry powerhouses
A separate study, also highlighted in the release, found that only a small handful of microbial species are prolific chemists — roughly three-quarters of antibiotics come from a single type of bacteria. The research, published in Nature Microbiology, identified a biological pattern explaining why only some microbes are chemistry powerhouses, which could help guide the search for urgently needed new medicines.
For university students studying health sciences, microbiology, or related fields, these advances represent potential new directions in drug development and clinical practice. The discoveries also underscore the growing role of interdisciplinary approaches — combining biochemistry, computer science, and genomics — in tackling one of the most pressing global health threats.